CONMED Corporation (CNMD)
Automate Your Wheel Strategy on CNMD
With Tiblio's Option Bot, you can configure your own wheel strategy including CNMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CNMD
- Rev/Share 42.9169
- Book/Share 32.404
- PB 1.3563
- Debt/Equity 0.8793
- CurrentRatio 2.231
- ROIC 0.0678
- MktCap 1361041578.0
- FreeCF/Share 4.7899
- PFCF 9.1812
- PE 12.3435
- Debt/Assets 0.3787
- DivYield 0.0182
- ROE 0.1137
- Rating A
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | CNMD | Needham | Buy | Hold | -- | -- | June 12, 2025 |
| Downgrade | CNMD | Stifel | Buy | Hold | -- | $55 | April 28, 2025 |
| Downgrade | CNMD | JP Morgan | Overweight | Neutral | $85 | $70 | Feb. 6, 2025 |
News
Conmed (CNMD) is a Top-Ranked Growth Stock: Should You Buy?
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Wall Street Analysts Think Conmed (CNMD) Could Surge 25.54%: Read This Before Placing a Bet
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Conmed (CNMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CNMD or MMSI: Which Is the Better Value Stock Right Now?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Conmed (CNMD) or Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
Read More
CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.
Read More
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Conmed (CNMD) is a Strong Value Stock
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.
Read More
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Conmed (CNMD) is a Strong Growth Stock
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD reports solid second-quarter results, driven by improving sales across both segments.
Read More
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
Read More
Conmed (CNMD) is a Top-Ranked Value Stock: Should You Buy?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors
Published: May 21, 2025 by: Business Wire
Sentiment: Neutral
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne's extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will continue to serve the Board and the Company well in her new role as Chair of the Board,” said Pat Beyer, P.
Read More
Here's Why Conmed (CNMD) is a Strong Value Stock
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD reports solid first-quarter results, driven by improving sales across both segments.
Read More
CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
CONMED Corporation (NYSE:CNMD ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Pat Beyer - Chief Executive Officer and President Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Robbie Marcus - JPMorgan Rick Wise - Stifel Young Li - Jefferies Travis Steed - Bank of America Mike Matson - Needham Operator Good day, and thank you for standing by. Welcome to CONMED's First Quarter Fiscal 2025 Earnings Conference Call.
Read More
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
Read More
About CONMED Corporation (CNMD)
- IPO Date 1987-07-23
- Website https://www.conmed.com
- Industry Medical - Devices
- CEO Patrick J. Beyer
- Employees 3900